Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

65.02 +1.28 (+2.01%)
Official Closing Price Updated: 4:10 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 237,411
Open 63.69
Bid (Size) 63.76 (39)
Ask (Size) 66.60 (38)
Prev. Close 63.74
Today's Range 63.69 - 65.42
52wk Range 58.97 - 73.28
Shares Outstanding 85,500
Dividend Yield 1.80%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Trump vows to slash drug prices with new executive order, potentially dropping them by 30-80%. 
Via Benzinga
Topics Government
Exposures Political
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Pharma ETFs closely watched as Trump's drug policies stir market volatility. Funds offer sector exposure but differ in risk levels and growth potential. 
Via Benzinga
Topics ETFs Government
Exposures Political

Performance

YTD
-0.9%
-0.9%
1 Month
+4.9%
+4.9%
3 Month
-7.2%
-7.2%
6 Month
-7.7%
-7.7%
1 Year
-1.0%
-1.0%

More News

Read More
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report
Via Stocktwits
Topics Government Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Via Benzinga
Topics Government
Exposures Political
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Via Benzinga
Topics ETFs
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On?
Via Benzinga
Topics World Trade
Exposures Tariff
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
Via Benzinga
Topics ETFs Government World Trade
Exposures Political Tariff
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
Via Benzinga
US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget
Via Benzinga
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Via Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Via Benzinga
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Via Benzinga
Topics ETFs
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
Via Benzinga
Topics Government
Exposures Political Product Safety
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
Via Benzinga
Topics Government
Exposures Political
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Via Talk Markets
Topics ETFs
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Via Benzinga
Topics Stocks
Exposures US Equities
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
Via Benzinga
A Look At Pharma ETFs After Q4 Earnings
Via Talk Markets
Topics ETFs
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge
Via Benzinga
Topics Bonds
Exposures Debt Markets
3 Beaten-Down ETFs To Buy For A Turnaround In 2024
Via Talk Markets
Topics ETFs
Exposures COVID-19
5 Secret Santa ETFs That Might Surprise You This Christmas
Via Talk Markets
Topics ETFs
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
Via Benzinga
5 Sector ETFs That Outperformed in Turbulent August
Via Talk Markets
Topics ETFs

Frequently Asked Questions

Is iShares U.S. Pharmaceutical ETF publicly traded?
Yes, iShares U.S. Pharmaceutical ETF is publicly traded.
What exchange does iShares U.S. Pharmaceutical ETF trade on?
iShares U.S. Pharmaceutical ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares U.S. Pharmaceutical ETF?
The ticker symbol for iShares U.S. Pharmaceutical ETF is IHE on the New York Stock Exchange
What is the current price of iShares U.S. Pharmaceutical ETF?
The current price of iShares U.S. Pharmaceutical ETF is 65.02
When was iShares U.S. Pharmaceutical ETF last traded?
The last trade of iShares U.S. Pharmaceutical ETF was at 05/12/25 04:10 PM ET
What is the market capitalization of iShares U.S. Pharmaceutical ETF?
The market capitalization of iShares U.S. Pharmaceutical ETF is 5.56M
How many shares of iShares U.S. Pharmaceutical ETF are outstanding?
iShares U.S. Pharmaceutical ETF has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.